Bio Medica Laboratories Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | 15.94x | 36,000 | 574,000 | ₹1 Cr |
| NII (HNI) | 1.30x | 1,755,000 | 2,286,000 | ₹24 Cr |
| Retail | 2.92x | 1,792,000 | 5,228,000 | ₹25 Cr |
| Market Maker | — | 189,000 | — | ₹3 Cr |
| Σ Total | 2.26x | 3,583,000 | 8,088,000 | ₹50 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹139,000 |
| Retail (Max) | 13 | 13,000 | ₹1,807,000 |
| S-HNI (Min) | 14 | 14,000 | ₹1,946,000 |
| B-HNI (Min) | 67 | 67,000 | ₹9,313,000 |
Financial Statements Amount in ₹ Crore
| Metric | 30 Nov 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 29 | 38 | 15 |
| EBITDA | 13 | 15 | 6 |
| Profit After Tax | 9 | 10 | 3 |
| Net Worth | 17 | 15 | 5 |
| Total Assets | 65 | 39 | 20 |
| Reserves & Surplus | 8 | 6 | 5 |
| Total Borrowing | 38 | 15 | 10 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Repayment of loan – 6.50
- Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises – 28.50
- General Corporate Purposes –
- –
Company Overview
Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.
Product portfolio:
- Liquid Injectables: 58 products are offered under this category
- Dry powder injectables: 15 products under this category
It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications.
The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh.
It has two manufacturing facilities in Indore, Madhya Pradesh.
Competitive Strengths
- Multi-product capability and diversified product portfolio
- Experienced promoters, management and employees.
- Quality assurance
- Established client relationship